Lipella Pharmaceuticals Inc. Common Stock Financial Flexibility Index
Lipella Pharmaceuticals Inc. Common Stock financial flexibility index. Lipella Pharmaceuticals Inc. Common Stock (LIPO) has a Financial Flexibility Index of -2734.54x as of September 2025. Free cash flow of $-2.36 Billion (operating CF $-2.36 Billion minus capex $0.00) represents -2735% of total liabilities ($862.22K). Check LIPO asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Lipella Pharmaceuticals Inc. Common Stock (2019–2024)
Financial flexibility index of Lipella Pharmaceuticals Inc. Common Stock from 2019 to 2024. Historical Financial Flexibility Index trend for Lipella Pharmaceuticals Inc. Common Stock across 6 annual periods. Explore Lipella Pharmaceuticals Inc. Common Stoc debt service capacity to assess how comfortably operating cash covers total debt obligations.
Lipella Pharmaceuticals Inc. Common Stock Financial Flexibility Index by Year (2019–2024)
Lipella Pharmaceuticals Inc. Common Stock financial flexibility index by year from 2019 to 2024. Year-by-year free cash flow to debt coverage for Lipella Pharmaceuticals Inc. Common Stock. For the full cash flow conversion analysis, see LIPO operating cash flow.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -5.24x | $-3.95 Million | $-3.95 Million | $754.42K | ▲ +27.7% |
| 2023 | -7.25x | $-3.14 Million | $-3.15 Million | $432.73K | ▼ -404.4% |
| 2022 | -1.44x | $-1.83 Million | $-1.83 Million | $1.27 Million | ▲ +14.4% |
| 2021 | -1.68x | $-989.27K | $-989.27K | $589.34K | ▼ -2788.3% |
| 2020 | -0.06x | $-28.58K | $-28.58K | $491.70K | ▲ +64.7% |
| 2019 | -0.16x | $-39.12K | $-39.12K | $237.26K | — |